drugset
drugset / Trial / NCT04380857

Assessing Dextenza Insert After SMILE Procedure

NCT04380857 ↗

Phase 4 Completed 20 enrolled William Wiley, MD
RandomizedParallel-groupOpen-labelTreatment

Summary

This three-month prospective, open-label, single-center, randomized investigator initiated clinical study seeks to investigate the efficacy of DEXTENZA when placed in the lower canaliculus (study eye) compared to topical corticosteroids (control eye) following bilateral SMILE surgery. In addition, the study will evaluate physician assessment of ease of DEXTENZA insertion

Timeline

Start
2020-06-18
Primary completion
2021-06-21
Completion
2021-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Comparator Prednisolone Other / unclassified — Topical

Indications

No indication recorded.